Gynecomastia and Its Management In Boys With Partial Androgen Insensitivity Syndrome.

IF 5 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Supitcha Patjamontri, Angela K Lucas-Herald, Jillian Bryce, Erica van den Akker, Martine Cools, Evgenia Globa, Gil Guerra-Junior, Olaf Hiort, Paul Hofman, Paul-Martin Holterhus, Ieuan A Hughes, Anders Juul, Anna Nordenstrom, Gianni Russo, Marianna R Stancampiano, Sumudu N Seneviratne, Rieko Tadokoro-Cuccaro, Ajay Thankamony, Naomi Weintrob, Natalia Zelinska, S Faisal Ahmed
{"title":"Gynecomastia and Its Management In Boys With Partial Androgen Insensitivity Syndrome.","authors":"Supitcha Patjamontri, Angela K Lucas-Herald, Jillian Bryce, Erica van den Akker, Martine Cools, Evgenia Globa, Gil Guerra-Junior, Olaf Hiort, Paul Hofman, Paul-Martin Holterhus, Ieuan A Hughes, Anders Juul, Anna Nordenstrom, Gianni Russo, Marianna R Stancampiano, Sumudu N Seneviratne, Rieko Tadokoro-Cuccaro, Ajay Thankamony, Naomi Weintrob, Natalia Zelinska, S Faisal Ahmed","doi":"10.1210/clinem/dgae562","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Partial androgen insensitivity syndrome (PAIS) is a rare condition that is reported to be commonly associated with gynecomastia in males.</p><p><strong>Objectives: </strong>To assess the management of gynecomastia in male PAIS.</p><p><strong>Materials and methods: </strong>Retrospective review of males with PAIS over the age of 10 years in the I-DSD registry.</p><p><strong>Results: </strong>Of the 205 eligible cases, information was available for 57 from 13 centers. An androgen receptor gene variant was confirmed in 45 (79%) with a median age at first presentation of 1.0 year (range 0.1, 26.0). Of the 45 genetically confirmed cases, gynecomastia was present in 41 (91%) with a median age at the time of gynecomastia development of 13.5 years (11.0, 29.0). In the other 4 (9%) with no gynecomastia, the median age at last assessment was 15.7 years (10.6, 17.0). In 30 cases with information available, micropenis was present at the time of gynecomastia development in 23 (77%). Of the 35 with information available, 2 (6%) exhibited spontaneous resolution between the ages of 15 and 21 years and 25 (71%) had breast surgery at a median age of 15.7 years (14.0, 23.0). Of these 25, 9 (26%) had previously received medical therapy. The median clinician score of effectiveness for medical therapy was 3 (1, 8) compared to 10 (3, 10) for surgery (P < .0001). In 31 with information available, 13 (42%) had received psychology support.</p><p><strong>Conclusion: </strong>Gynecomastia is common in PAIS but not universal. Surgical management may be more effective than medical therapy, but there is a need for further standardized and systematic studies.</p>","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":null,"pages":null},"PeriodicalIF":5.0000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/clinem/dgae562","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Partial androgen insensitivity syndrome (PAIS) is a rare condition that is reported to be commonly associated with gynecomastia in males.

Objectives: To assess the management of gynecomastia in male PAIS.

Materials and methods: Retrospective review of males with PAIS over the age of 10 years in the I-DSD registry.

Results: Of the 205 eligible cases, information was available for 57 from 13 centers. An androgen receptor gene variant was confirmed in 45 (79%) with a median age at first presentation of 1.0 year (range 0.1, 26.0). Of the 45 genetically confirmed cases, gynecomastia was present in 41 (91%) with a median age at the time of gynecomastia development of 13.5 years (11.0, 29.0). In the other 4 (9%) with no gynecomastia, the median age at last assessment was 15.7 years (10.6, 17.0). In 30 cases with information available, micropenis was present at the time of gynecomastia development in 23 (77%). Of the 35 with information available, 2 (6%) exhibited spontaneous resolution between the ages of 15 and 21 years and 25 (71%) had breast surgery at a median age of 15.7 years (14.0, 23.0). Of these 25, 9 (26%) had previously received medical therapy. The median clinician score of effectiveness for medical therapy was 3 (1, 8) compared to 10 (3, 10) for surgery (P < .0001). In 31 with information available, 13 (42%) had received psychology support.

Conclusion: Gynecomastia is common in PAIS but not universal. Surgical management may be more effective than medical therapy, but there is a need for further standardized and systematic studies.

部分雄激素不敏感综合征男孩的妇科炎症及其治疗。
导言:部分雄激素不敏感综合征(PAIS)是一种罕见的疾病,据报道通常与男性妇科乳腺增生有关:评估男性 PAIS 中妇科乳腺增生的处理方法:材料:对I-DSD登记的10岁以上男性PAIS患者进行回顾性研究:结果:在符合条件的 205 个病例中,有 57 个病例的信息来自 13 个中心。45例(79%)患者的雄激素受体基因变异得到证实,首次发病的中位年龄为1.0岁(0.1-26.0岁)。在这 45 例基因确诊病例中,41 例(91%)出现了妇科炎症,出现妇科炎症时的中位年龄为 13.5 岁(11.0-29.0 岁)。另外 4 例(9%)没有妇科乳房,最后一次评估的中位年龄为 15.7 岁(10.6,17.0)。在 30 例可提供信息的病例中,有 23 例(77%)在出现妇科炎症时存在小阴茎。在 35 例有资料可查的病例中,有 2 例(6%)在 15 至 21 岁期间表现为自发消退,25 例(71%)在中位年龄 15.7 岁(14.0 至 23.0 岁)时进行了乳房手术。在这 25 人中,有 9 人(26%)曾接受过药物治疗。临床医生对药物治疗效果的中位评分为 3(1,8)分,而对手术治疗效果的中位评分为 10(3,10)分(P < .0001)。在31名提供信息的患者中,13人(42%)曾接受过心理辅导:结论:妇科炎症在 PAIS 中很常见,但并不普遍。手术治疗可能比药物治疗更有效,但还需要进一步的标准化和系统化研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Endocrinology & Metabolism
Journal of Clinical Endocrinology & Metabolism 医学-内分泌学与代谢
CiteScore
11.40
自引率
5.20%
发文量
673
审稿时长
1 months
期刊介绍: The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信